Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

Nature Medicine

Volumn 9, Issue 5, 2003, Pages 604-613

  Cao, Renhai ^a   Bråkenhielm, Ebba ^a   Pawliuk, Robert ^b   Wariaro, David ^c   Post, Mark J ^d   Wahlberg, Eric ^c   Leboulch, Philippe ^b,e,f   Cao, Yihai ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Genetix Pharmaceuticals   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; FEMORAL ARTERY; GENE EXPRESSION; HINDLIMB; LIMB BLOOD FLOW; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; COLLATERAL CIRCULATION; DRUG SYNERGISM; FIBROBLAST GROWTH FACTOR 2; HINDLIMB; ISCHEMIA; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR; RABBITS; RATS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0038363443     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm848     Document Type: Article

References (30)

1. Folkman, I. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757-1763 (1995).
2. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
3. Zetter, B.R. Hold that line. Angiomotin regulates endothelial cell motility. J. Cell. Biol. 152, F35-F36 (2001).
4. Dvorak, H.F. VPF/VEGF and the angiogenic response. Semin. Perinatol. 24, 75-78 (2000).
5. Freedman, S.B. & Isner, J.M. Therapeutic angiogenesis for coronary artery disease. Ann. Intern. Med. 136, 54-71 (2002).
6. Isner, J.M. Myocardial gene therapy. Nature 415, 234-239 (2002).
7. Waltenberger, J. Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation 96, 4083-4094 (1997).
8. Carmeliet, P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat. Med. 6, 1102-1103 (2000).
9. Ferrara, N. & Alitalo, K. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5, 1359-1364 (1999).
10. Yancopoulos, G.D. et al. Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248 (2000).
11. Epstein, S.E., Kornowski, R., Fuchs, S. & Dvorak, H.F. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104, 115-119 (2001).
12. Hendel, R.C. et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 101, 118-121 (2000).
13. Celletti, F.L. et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 7, 425-429 (2001).
14. Lee, R.J. et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102, 898-901 (2000).
15. Ferrara, N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2, 795-803 (2002).
16. Senger, D.R. et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985 (1983).
17. Shing, Y. et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223, 1296-1299 (1984).
18. Ataliotis, P. & Mercola, M. Distribution and functions of platelet-derived growth factors and their receptors during embryogenesis. Int. Rev. Cytol. 172, 95-127 (1997).
19. Holmgren, L., Claesson-Welsh, L., Heldin, C.H. & Ohlsson, R. The expression of PDGF α- and β-receptors in subpopulations of PDGF-producing cells implicates autocrine stimulatory loops in the control of proliferation in cytotrophoblasts that have invaded the maternal endometrium. Growth Factors 6, 219-231 (1992).
20. Lindahl, P., Johansson, B.R., Leveen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245 (1997).
21. Carmeliet, P. & Conway, E.M. Growing better blood vessels. Nat. Biotechnol. 19, 1019-1020 (2001).
22. Richardson, T.P., Peters, M.C., Ennett, A.B. & Mooney, D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19, 1029-1034 (2001).
23. Yarden, Y. et al. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323, 226-232 (1986).
24. Simons, M. et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105, 788-793 (2002).
25. Omura, T., Heldin, C.H. & Ostman, A. Immunoglobulin-like domain 4-mediated receptor-receptor interactions contribute to platelet-derived growth factor-induced receptor dimerization. J. Biol. Chem. 272, 12676-12682 (1997).
26. Cao, Y. et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 95, 14389-14394 (1998).
27. Passaniti, A. et al. Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int. J. Cancer 51, 318-324 (1992).
28. Seifert, F.C., Banker, M., Lane, B., Bagge, U. & Anagnostopoulos, C.E. An evaluation of resting arterial ischemia models in the rat hind limb. J. Cardiovasc. Surg. (Torino) 26, 502-508 (1985).
29. Essex, T.J. & Byrne, P.O. A laser Doppler scanner for imaging blood flow in skin. J. Biomed. Eng. 13, 189-194 (1991).
30. Wang, C., Kelly, J., Bowen-Pope, D.F. & Stiles, C.D. Retinoic acid promotes transcription of the platelet-derived growth factor α-receptor gene. Mol. Cell Biol. 10, 6781-6784 (1990).